Carisma Therapeutics Inc Sustainability Reports

Carisma Therapeutics Inc. specializes in developing innovative CAR-M cell therapies for cancer treatment.

Sector: Health Care

Country: United States

Exchange: Nasdaq Stock Market

ISIN: US14216R1014

2 reports from 2023 to 2024

Company Profile

Carisma Therapeutics Inc

Carisma Therapeutics Inc. specializes in developing innovative CAR-M cell therapies for cancer treatment.

MIC

 

Ticker

 

ISIN

 

Website

www.sesenbio.com

Country

United States

Exchange

Nasdaq Stock Market

Sector

Health Care

Industry

Pharmaceuticals, Biotechnology & Life Sciences

Reports

Available reports